Raymond James Financial’s DiaMedica Therapeutics DMAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$61.5K Buy
15,767
+100
+0.6% +$390 ﹤0.01% 5045
2025
Q1
$59.4K Buy
15,667
+400
+3% +$1.52K ﹤0.01% 4568
2024
Q4
$82.9K Buy
+15,267
New +$82.9K ﹤0.01% 4506